Ginkgo automation works with aura genetics to accelerate tests and innovation of direct consumers

Ginkgo automation works with aura genetics to accelerate tests and innovation of direct consumers

Ginkgo Biowork's contact with investor:
[email protected]

Ginkgo Biowork Media contact:
[email protected]

Aura genetics -media contact:
[email protected]

Future -oriented statements by Ginkgo Bioworks

This press release contains certain future -oriented statements in the sense of federal securities laws, including statements about the skills and potential success of the partnership and the cell programming of Ginkgo. These future -oriented statements are generally “believed”, “project”, “potential”, “expectation”, “anticipated”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” “” Projections and other statements about future events that are based on current expectations and assumptions and are therefore subject to risks and uncertainties. Many factors could lead to actual future events in this press release significantly from the future-oriented statements, including but not limited: (i) Our ability to realize short-term and long-term cost savings in connection with our location consolidation plans, including the ability to terminate lease or find sub-matters for non-used institutions. Ginkgo operates and plans to operate the operations between the competitors and changes in the laws and regulations that influence the business of Ginkgo, (III) The ability to implement and identify and implement additional business plans, forecasts and other expectations, and to identify and identify additional business opportunities for our solutions and tools, and the risk for the needs of needs from Synthesis and the uncertainty that with synthesis -Bio products, in relation to the needs requirements, in terms of synthesis -Bio products, synthetic biology, (V.). Bio -security services, (VI) Changes in the Biosecurity industry, including progress in technology, the emerging competition and the development of industry requirements, standards and regulations, (VII). The result of a pending or potential legal procedure against Ginkgo (VIII). We can use the expected advantages and the successful advantages and the successful, from our Foodry platform programs and codesbase -assets and codesbase -assets and codesbase -assets, IX -Assets and Codesbase -Assets, and Codesbase -Assets, (IX). Packages or other services, (X) The product development, production or manufacturing success of our customers, (XI) our exposure to volatility and liquidity risks, which are inherent in the participation of equity in other operational companies, and other non -payment -related consideration that we can receive for our services (XII). Government authorities assigned. The above list of factors is not exhaustive. You should carefully check the above factors and the other risks and uncertainties, which were submitted in the “Risk Factors” section of the annual report of Ginkgo on form 10-K February 25, 2025 And other documents submitted by Ginkgo from time to time with the Sec. These submissions identify and treat other important risks and uncertainties that can lead to actual events and results significantly differentiate between those that are contained in the future -oriented statements. Future -oriented statements only speak at the time of the date at which they are made. Readers are warned not to be inappropriately for future statements, and Ginkgo assumes no obligation and does not intend to update or revise these future -oriented statements, be it based on new information, future events or in any other way. Ginkgo does not provide any assurance that it will meet its expectations.

Source Ginkgo Bioworks

Ginkgo automation works with aura genetics to accelerate tests and innovation of direct consumers

Leave a comment

Your email address will not be published. Required fields are marked *